Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000415EBVENSG00000136750.13protein_codingGAD2NoNo2572Q05329
Q5VZ30
TVIS30027374HIVENSG00000136750.13protein_codingGAD2NoNo2572Q05329
Q5VZ30
TVIS30019930HIVENSG00000136750.13protein_codingGAD2NoNo2572Q05329
Q5VZ30
TVIS44026405HTLV-1ENSG00000136750.13protein_codingGAD2NoNo2572Q05329
Q5VZ30
TCGA Plot Options
Drug Information
GeneGAD2
DrugBank IDDB00114
Drug NamePyridoxal phosphate
Target IDBE0000602
UniProt IDQ05329
Regulation Typecofactor
PubMed IDs10978228
CitationsCormier-Daire V, Dagoneau N, Nabbout R, Burglen L, Penet C, Soufflet C, Desguerre I, Munnich A, Dulac O: A gene for pyridoxine-dependent epilepsy maps to chromosome 5q31. Am J Hum Genet. 2000 Oct;67(4):991-3. Epub 2000 Sep 7.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationPyridoxals and derivatives
SMILESCC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
PathwaysHistidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling
PharmGKBPA164749650
ChEMBLCHEMBL82202